NanoBio and GSK progress OTC cold sore treatment to Phase III
This article was originally published in Scrip
Executive Summary
The privatelyheld biopharmaceutical company NanoBio and GlaxoSmithKline Consumer Healthcare have begun two Phase III trials of their over-the-counter (OTC) cold sore treatment, NB-001.